Table 3.
Zero mark-up | EMs/Rx number (%) | EM number | Total drug number | EMs/Rx cost (%) | EM cost (RMB) | Total Rx cost (RMB) |
---|---|---|---|---|---|---|
Hypertension | ||||||
Adopted | 100 | 2 | 2 | 100 | 30.2 | 65.5 |
(299) | (60–100) | (1–3) | (2–3) | (39–100) | (14.0-83.3) | (17.6-140.3) |
Not adopted | 75** | 2** | 3** | 64** | 51.3** | 102.1** |
(759) | (50–100) | (1–3) | (2–5) | (26–100) | (20.0-97.6) | (54.1-200.8) |
Diabetes | ||||||
Adopted | 67 | 2 | 3 | 56 | 24.5 | 100.5 |
(304) | (50–100) | (1–3) | (2–3) | (13–100) | (9.6-105.3) | (39.9-189.3) |
Not adopted | 100** | 2 | 3 | 99** | 85.4** | 136.0** |
(860) | (50–100) | (1–3) | (1–4) | (52–100) | (38.7-180.9) | (69.5-261.1) |
Gout | ||||||
Adopted | 75 | 3 | 3 | 66 | 11.6 | 30.5 |
(232) | (50–100) | (1–4) | (3–5) | (14–100) | (4.3-25.3) | (13.8-82.1) |
Not adopted | 75 | 2** | 3** | 84 | 21.0** | 35.9 |
(724) | (50–100) | (1–4) | (2–4) | (21–100) | (5.2-31.5) | (21.4-62.1) |
Bacterial infections | ||||||
Adopted | 60 | 2 | 3 | 55 | 32.6 | 76.0 |
(297) | (30–100) | (1–3) | (2–4) | (8–100) | (3.6-71.5) | (42.0-117.9) |
Not adopted | 60 | 2** | 3** | 43 | 31.0 | 88.6** |
(899) | (40–80) | (1–3) | (3–5) | (14–88) | (12.2-65.3) | (53.2-139.4) |
Rx = prescription; EMs = essential medicines.
On June 1, 2012, at the beginning of the survey, the conversion rate was RMB 6.33 to USD 1.00. Data are shown as medians (25th–75th interquartile range). **p < 0.01 compared with the zero mark-up group.